This is consistent with a previous report that demonstrated that TGFβ signaling in wild‐type BRCA1/2 breast cancers down‐regulates HR gene expression, and renders breast cancer cells more sensitive to PARPi (Liu et al, 2014). The gene discussed is BRCA1; the disease is breast carcinoma.